Pharmacokinetics of Cryptotanshinone and Its Metabolites Between Traditional Decoction Piece and Ultrafine Granular Powder of Salvia Miltiorrhiza

ZHENG Lingjie,DENG Wen,XING Lu,ZHANG Wei,TAN Zhirong,ZHOU Honghao,CHENG Jinle
2017-01-01
Abstract:AIM:To study the pharmacokinetics and bioequivalence of cryptotanshinone and its metabolites tanshinone ⅡA between traditional decoction piece and ultrafine granular powder of salvia miltiorrhiza.METHODS:Twenty-four healthy volunteers,half male and half female were orally administrated with a single dose of subject drug (ultrafine granular powder of salvia miltiorrhiza) and reference drug (traditional decoction piece of salvia miltiorrhiza).Plasma concentrations of cryptotanshinone and tanshinone ⅡA were determined by a validated LC-MS method.Collected data were calculated and analyzed by DAS Ver3.2.2 and SPSS software.After logarithmic transformation of AUC0-60 and Cmax,one-sided t-test was performed and 90% confidence interval was calculated.RESULTS:The main pharmacokinetics parameters of cryptotanshinone and tanshinone ⅡA in subject drug and reference drug including Tmax,Cmax,AUC0-60 and t1/2 exhibited no significant difference (P > 0.05) between different periods and different genders,while significant difference was observed between different preparations (P < 0.05).The relative bioavailability of subject drug and reference drug were as follow:(4 456.8 ±3 706.8)%,(4 690.3 ±3 416.7) %.CONCLUSION:The bioavailability of cryptotanshinone and tanshinone ⅡA in ultrafine granular powder is significantly higher than traditional decoction piece,which is referential for reducing dosage in clinical application.
What problem does this paper attempt to address?